lung cancer Archives | Page 2 of 3 | Be Korea-savvy
World Conference on Lung Cancer Monday Press Conference: Clinical Research Results and Gender Differences in Lung Cancer Survival

World Conference on Lung Cancer Monday Press Conference: Clinical Research Results and Gender Differences in Lung Cancer Survival

TORONTO, Sept. 24 (Korea Bizwire) — At today’s press conference at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC), conference co-president Dr. Andrea Bezjak, M.D., FRCPC, MSc, professor in the Departments of Radiation Oncology and Health Policy, Management and Evaluation at the University of Toronto and [...]

Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer

Researchers, Survivors, Advocates and Physicians Convene to Discuss Innovations in Lung Cancer Research, Treatment and Advocacy at the Largest-Attended World Conference on Lung Cancer

TORONTO, Sept. 23 (Korea Bizwire) — Patients, survivors and advocates joined researchers and physicians from across the globe to discuss the future of lung cancer at the International Association for the Study of Lung Cancer’s (IASLC’s) 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada. The conference’s first press briefing highlighted the record-breaking number [...]

The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada

The IASLC 19th World Conference on Lung Cancer Arrives in Toronto, Canada

DENVER, Aug. 21 (Korea Bizwire) – What: The International Association for the Study of Lung Cancer (IASLC) presents the IASLC 19th World Conference on Lung Cancer (WCLC) on September 23-26, 2018, in Toronto, Canada. The WCLC is the world’s largest meeting dedicated solely to lung cancer and other thoracic malignancies, and is expected to convene over 7,000 [...]

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer

NEW YORK, Aug. 13 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that preliminary safety and efficacy data from a Phase 1/2 clinical trial of CK-101 (also known as RX518), a [...]

Lung Cancer Survivors Suffer from Fatigue, Poor Quality of Life

Lung Cancer Survivors Suffer from Fatigue, Poor Quality of Life

SEOUL, March 5 (Korea Bizwire) – A new study has revealed lung cancer survivors face significant hardships due to chronic fatigue. Lung cancer patients face a low quality of life even after being treated successfully, as a result of chronic fatigue that significantly worsens one’s physical and psychological ability, the research team led by professors Yun [...]

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer

Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer

DENVER, Jan. 23 (Korea Bizwire) — Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay apace and provide optimal patient care, three leading medical societies—the College of American [...]

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer

YOKOHAMA, Japan, Oct. 18 (Korea Bizwire) — The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung [...]

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions

YOKOHAMA, Japan, Oct. 17 (Korea Bizwire) — Today’s press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured groundbreaking findings in the study of both small cell and non-small cell lung cancer. The studies presented covered broad research areas, from confirmation of existing classification [...]